Kodiak Sciences, Inc. (KOD)
99.87
+5.61
(+5.95%)
USD |
NASDAQ |
Oct 09, 16:00
100.13
+0.26
(+0.26%)
After-Hours: 20:00
Kodiak Sciences Free Cash Flow : -159.90M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -159.90M |
| March 31, 2026 | -148.12M |
| December 31, 2025 | -136.51M |
| September 30, 2025 | -127.29M |
| June 30, 2025 | -115.71M |
| March 31, 2025 | -107.44M |
| December 31, 2024 | -117.72M |
| September 30, 2024 | -147.25M |
| June 30, 2024 | -158.88M |
| March 31, 2024 | -175.76M |
| December 31, 2023 | -195.61M |
| September 30, 2023 | -196.58M |
| June 30, 2023 | -223.95M |
| March 31, 2023 | -251.84M |
| Date | Value |
|---|---|
| December 31, 2022 | -253.82M |
| September 30, 2022 | -263.02M |
| June 30, 2022 | -286.32M |
| March 31, 2022 | -265.61M |
| December 31, 2021 | -245.57M |
| September 30, 2021 | -207.84M |
| June 30, 2021 | -150.36M |
| March 31, 2021 | -113.72M |
| December 31, 2020 | -90.43M |
| September 30, 2020 | -69.71M |
| June 30, 2020 | -51.39M |
| March 31, 2020 | -50.48M |
| December 31, 2019 | -39.58M |
| September 30, 2019 | -37.00M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Regeneron Pharmaceuticals, Inc. | 3.575B |
| AbbVie, Inc. | 18.21B |
| Mirum Pharmaceuticals, Inc. | -263.74M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -46.24M |
| Cash from Investing (Quarterly) | -0.352M |
| Cash from Financing (Quarterly) | 2.963M |
| Free Cash Flow Per Share (Quarterly) | -0.7439 |
| Free Cash Flow to Equity (Quarterly) | -43.35M |
| Free Cash Flow to Firm (Quarterly) | -46.59M |
| Free Cash Flow Yield | -2.76% |